Jazz Pharma Plc (JAZZ)
101.64 x 1 116.85 x 1
Post-market by (Cboe BZX)
112.89 +2.09 (+1.89%) 04/28/25 [NASDAQ]
101.64 x 1 116.85 x 1
Post-market 113.15 +0.26 (+0.23%) 16:01 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | JAZZ | ROIV | RGEN | ||
| Company | Jazz Pharma Plc | Roivant Sciences Ltd | Repligen Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 111.22 | 11.05 | 145.60 | ||
| High | 114.47 | 11.22 | 148.38 | ||
| Low | 111.22 | 11.01 | 140.14 | ||
| Last | 112.89 | 11.19 | 143.63 | ||
| Change | +2.09 | +0.18 | -1.12 | ||
| % Change | +1.89% | +1.63% | -0.77% | ||
| Volume | 822,100 | 8,302,100 | 863,600 | ||
| 20-Day Average Volume | 1,318,765 | 7,763,240 | 971,215 | ||
| Previous Close | 110.80 | 11.01 | 144.75 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 108.92 | 10.10 | 128.44 | ||
| 20-Day Raw Stochastic | 53.74% | 98.80% | 88.45% | ||
| 20-Day Relative Strength | 46.03% | 60.18% | 53.84% | ||
| Weighted Alpha | -1.75 | -1.26 | -10.90 | ||
| Today's Opinion | 24% Sell | 40% Sell | 48% Sell | ||
| Previous Opinion | 24% Sell | 40% Sell | 48% Sell | ||
| Last Month's Opinion | 40% Buy | 96% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.51% since 04/21/25 | +11.45% since 04/21/25 | +9.11% since 04/21/25 | ||
| Low | 101.22 on 04/22/25 | 10.18 on 04/22/25 | 136.07 on 04/22/25 | ||
| High | 114.47 on 04/28/25 | 11.22 on 04/28/25 | 148.94 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | -8.16% since 03/28/25 | +7.80% since 03/28/25 | +7.66% since 03/28/25 | ||
| Low | 95.49 on 04/09/25 | 8.73 on 04/07/25 | 102.96 on 04/07/25 | ||
| High | 127.87 on 04/02/25 | 11.22 on 04/28/25 | 148.94 on 04/23/25 | ||
| 3-Month | |||||
| %Chg | -8.61% since 01/28/25 | +0.36% since 01/28/25 | -17.57% since 01/28/25 | ||
| Low | 95.49 on 04/09/25 | 8.73 on 04/07/25 | 102.96 on 04/07/25 | ||
| High | 148.06 on 02/26/25 | 11.51 on 02/10/25 | 177.17 on 01/30/25 | ||
| 6-Month | |||||
| %Chg | +1.36% since 10/28/24 | -5.49% since 10/28/24 | +4.68% since 10/28/24 | ||
| Low | 95.49 on 04/09/25 | 8.73 on 04/07/25 | 102.96 on 04/07/25 | ||
| High | 148.06 on 02/26/25 | 12.94 on 11/25/24 | 182.52 on 01/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,682,948 | 6,750,174 | 6,285,318 | ||
| Shares Outstanding, K | 60,732 | 713,549 | 56,149 | ||
| Annual Sales | 4,068,950,000 | 124,800,000 | 634,440,000 | ||
| Annual Net Income | 560,120,000 | 4,348,930,000 | -25,510,000 | ||
| Last Quarter Sales | 1,088,170,000 | 9,020,000 | 174,150,000 | ||
| Last Quarter Net Income | 191,120,000 | 169,380,000 | -30,280,000 | ||
| 60-Month Beta | 0.42 | 1.25 | 1.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 6.60 on 02/25/25 | -0.13 on 02/10/25 | 0.44 on 02/20/25 | ||
| Latest Earnings Date | 05/06/25 | 05/29/25 | 04/29/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 6.08 | 0.00 | 97.80 | ||